[PDF][PDF] mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes

…, A Kulczycki, TL Mantia, CC O'Shaughnessy… - Cell Reports …, 2022 - cell.com
Individuals with primary antibody deficiency (PAD) syndromes have poor humoral immune
responses requiring immunoglobulin replacement therapy. We followed individuals with PAD …

[HTML][HTML] Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity

…, P Desai, S Raju, TL Mantia, CC O'Shaughnessy… - JCI …, 2024 - Am Soc Clin Investig
… SARS-CoV-2 variant name above the graph in C and D indicates the most prevalent
circulating strain in the United States during the month in which IVIG/SCIG was infused (C) or …

Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity

…, P Desai, S Raju, TL Mantia, CC O'Shaughnessy… - JCI …, 2024 - Am Soc Clin Investig
… SARS-CoV-2 variant name above the graph in C and D indicates the most prevalent
circulating strain in the United States during the month in which IVIG/SCIG was infused (C) or …

SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients

…, A Kulczycki, TL Mantia, CC O'Shaughnessy… - Frontiers in …, 2022 - frontiersin.org
Background Although SARS-CoV-2 vaccines have proven effective in eliciting a protective
immune response in healthy individuals, their ability to induce a durable immune response in …

mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in patients with antibody deficiency syndromes

…, A Kulczycki, TL Mantia, CC O'Shaughnessy… - medRxiv, 2022 - medrxiv.org
Patients with primary antibody deficiency syndromes (PAD) have poor humoral immune
responses requiring immunoglobulin replacement therapy. We followed PAD patients after …

Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination

…, Z Ren, A Kau, T Mantia, C O'Shaughnessy… - Journal of Allergy and …, 2022 - jacionline.org
Methods Twenty-nine eligible patients were recruited. Blood samples are being collected
after complete vaccination with optional samples pre-vaccination, 60, 90 and 150 days post …

Sexual violence among a cohort of injection drug users

…, MV O'Shaughnessy, A Schilder, C Johnston… - Social Science & …, 2003 - Elsevier
The objective of this study was to determine the prevalence of, and factors associated with,
sexual violence in childhood, adolescence and adulthood, among injection drug using men …

A revolution reconsidered? Examining the practice of qualitative research in feminist scholarship

S O'Shaughnessy, NT Krogman - Signs: Journal of Women …, 2012 - journals.uchicago.edu
One of feminism’s most notable objectives is to revolutionize the practice of empirical inquiry.
Many feminist scholars have advocated the adoption of qualitative research methods …

Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?

…, T Kerr, RS Hogg, JSG Montaner, MV O'Shaughnessy… - Cmaj, 2001 - Can Med Assoc
Background: In several European countries safer injecting rooms have reduced the public
disorder and health-related problems of injection drug use. We explored factors associated …

Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme

…, K Li, RS Hogg, JSG Montaner, MV O'Shaughnessy… - Aids, 2002 - journals.lww.com
Vancouver has experienced an explosive HIV epidemic despite the presence of a needle
exchange programme (NEP). We sought possible explanations for high-risk syringe sharing …